• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

QSAR 研究一系列芳基羧酸酰胺衍生物作为二氢乳清酸脱氢酶(DHODH)潜在抑制剂。

QSAR study on a series of aryl carboxylic acid amide derivatives as potential inhibitors of dihydroorotate dehydrogenase (DHODH).

机构信息

Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, S.G. Highway, Chharodi, Ahmedabad, 382 481, Gujarat, India.

出版信息

Med Chem. 2013 Mar;9(2):222-39. doi: 10.2174/1573406411309020007.

DOI:10.2174/1573406411309020007
PMID:22920152
Abstract

QSAR study was performed on a series of aryl carboxylic acid amide derivatives (62 analogs) to establish structural features required for human dihydroorotate dehydrogenase (hDHODH) inhibition. Statistical significant QSAR models were developed for the prediction of hDHODH inhibitory activity by applying MLR analysis (r2 = 0.851 and q2 = 0.795), PCR analysis (r2 = 0.713 and q2 = 0.667) and PLS analysis (r2 = 0.848 and q2 = 0.802). QSAR study emphasized the importance of topological, estate number, hydrophobic and alignment independent descriptors for the prediction of hDHODH inhibitory activity. SaasCcount descriptor suggested the presence of carbon atoms in five member aryl ring system. Positive impact of alignment independent descriptors reveals the presence of carbonyl oxygen and chloro group in this series of compounds. DistTopo signifies basic connectivity of atoms in the molecules. High degree of predictability of the proposed QSAR models offers a great potential for the design and development of potent hDHODH inhibitors.

摘要

QSAR 研究对一系列芳基羧酸酰胺衍生物(62 个类似物)进行了研究,以确定抑制人二氢乳清酸脱氢酶(hDHODH)所需的结构特征。通过应用 MLR 分析(r2 = 0.851,q2 = 0.795)、PCR 分析(r2 = 0.713,q2 = 0.667)和 PLS 分析(r2 = 0.848,q2 = 0.802),为预测 hDHODH 抑制活性开发了具有统计学意义的 QSAR 模型。QSAR 研究强调拓扑、电子数、疏水性和独立于排列的描述符对于预测 hDHODH 抑制活性的重要性。SaasCcount 描述符表明五员芳环系统中存在碳原子。独立于排列的描述符的积极影响表明该系列化合物中存在羰基氧和氯基团。DistTopo 表示分子中原子的基本连接性。所提出的 QSAR 模型具有高度的可预测性,为设计和开发有效的 hDHODH 抑制剂提供了巨大潜力。

相似文献

1
QSAR study on a series of aryl carboxylic acid amide derivatives as potential inhibitors of dihydroorotate dehydrogenase (DHODH).QSAR 研究一系列芳基羧酸酰胺衍生物作为二氢乳清酸脱氢酶(DHODH)潜在抑制剂。
Med Chem. 2013 Mar;9(2):222-39. doi: 10.2174/1573406411309020007.
2
CoMFA and CoMSIA studies on aryl carboxylic acid amide derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors.基于芳基羧酸酰胺衍生物作为二氢乳清酸脱氢酶(DHODH)抑制剂的比较分子力场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)研究
Curr Comput Aided Drug Des. 2012 Dec 1;8(4):271-82. doi: 10.2174/157340912803519598.
3
Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase.疟原虫二氢乳清酸脱氢酶的布雷喹那类似物抑制剂的合成。
Bioorg Med Chem. 2005 Mar 15;13(6):1945-67. doi: 10.1016/j.bmc.2005.01.017.
4
Synthesis of 2-,4,-6-, and/or 7-substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents: 3D QSAR-assisted design.合成 2-、4-、6- 和/或 7-取代喹啉衍生物作为人二氢乳清酸脱氢酶 (hDHODH) 抑制剂和抗癌剂:3D QSAR 辅助设计。
Bioorg Med Chem Lett. 2019 Apr 1;29(7):917-922. doi: 10.1016/j.bmcl.2019.01.038. Epub 2019 Jan 31.
5
Biphenyl-4-ylcarbamoyl thiophene carboxylic acids as potent DHODH inhibitors.联苯-4-基甲酰基噻吩羧酸作为有效的二氢乳清酸脱氢酶抑制剂。
Bioorg Med Chem Lett. 2006 Jan 15;16(2):267-70. doi: 10.1016/j.bmcl.2005.10.011. Epub 2005 Oct 21.
6
Chemometric modeling, docking and in silico design of triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors as antimalarials.基于三唑并嘧啶的二氢乳清酸脱氢酶抑制剂的化学计量建模、对接和计算机辅助设计作为抗疟药。
Eur J Med Chem. 2010 Oct;45(10):4645-56. doi: 10.1016/j.ejmech.2010.07.034. Epub 2010 Jul 24.
7
Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents.新型取代喹啉-2-甲酰胺衍生物作为人二氢乳清酸脱氢酶(hDHODH)抑制剂和抗癌剂的设计、合成及药理评价
Eur J Med Chem. 2014 Jul 23;82:385-93. doi: 10.1016/j.ejmech.2014.05.064. Epub 2014 May 27.
8
Development of docking-based 3D QSAR models for the design of substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors.基于对接的 3D QSAR 模型的开发,用于设计取代的喹啉衍生物作为人二氢乳清酸脱氢酶(hDHODH)抑制剂。
SAR QSAR Environ Res. 2013 Aug;24(8):625-45. doi: 10.1080/1062936X.2013.792871. Epub 2013 May 28.
9
Design, synthesis and inhibitory activity against human dihydroorotate dehydrogenase (hDHODH) of 1,3-benzoazole derivatives bearing amide units.含酰胺单元的1,3-苯并唑衍生物的设计、合成及其对人二氢乳清酸脱氢酶(hDHODH)的抑制活性
Bioorg Med Chem Lett. 2016 Jul 1;26(13):3064-3066. doi: 10.1016/j.bmcl.2016.05.016. Epub 2016 May 7.
10
Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds.基于羟基化唑类支架的高效人二氢乳清酸脱氢酶抑制剂的设计、合成、生物学评价及X射线结构研究
Eur J Med Chem. 2017 Mar 31;129:287-302. doi: 10.1016/j.ejmech.2017.02.017. Epub 2017 Feb 14.

引用本文的文献

1
Development of a human dihydroorotate dehydrogenase (hDHODH) pharma-similarity index approach with scaffold-hopping strategy for the design of novel potential inhibitors.开发一种具有骨架跃迁策略的人二氢乳清酸脱氢酶(hDHODH)药物相似性指数方法,用于设计新型潜在抑制剂。
PLoS One. 2014 Feb 4;9(2):e87960. doi: 10.1371/journal.pone.0087960. eCollection 2014.